Wiens, K. E. et al. Building an integrated serosurveillance platform to inform public health interventions: insights from an experts’ meeting on serum biomarkers. PLoS Negl. Trop. Dis. 16, e0010657 (2022).
Cutts, F. T. & Hanson, M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop. Med. Int. Health 21, 1086–1098 (2016).
Carcelen, A. K., Hegde, A., Takahashi, S., Moss, S. & W. J. Serosurveillance Summit Meeting Report (Baltimore, MD, USA: Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center, 2023).
Arnold, B. F., Scobie, H. M., Priest, J. W. & Lammie, P. J. Integrated serologic surveillance of population immunity and disease transmission. Emerg. Infect. Dis. 24, 1188–1194 (2018).
Macicame, I. et al. Countrywide mortality surveillance for action in Mozambique: results from a national sample-based vital statistics system for mortality and cause of death. Am. J. Trop. Med. Hyg. 108, 5–16 (2023).
Anderson, R. M. & May, R. M. Directly transmitted infections diseases: control by vaccination. Science 215, 1053–1060 (1982).
Vos, R. A. et al. Seroepidemiology of measles, mumps and rubella on Bonaire, St. Eustatius and Saba: the first population-based serosurveillance study in Caribbean Netherlands. Vaccines (Basel) 7, 137 (2019).
Instituto Nacional de Saúde/INS, Instituto Nacional de Estatistica/INE, Programa Nacional de Controlo da Malária/PNCM, ICF. Mozambique Inquérito Nacional sobre Indicadores de Malária (IIM)2018. (Maputo, Mozambique: INS/Mozambique, INE, PNCM, ICF, 2019).
Bauhofer, A. F. L. et al. Intestinal protozoan infections among children 0-168 months with diarrhea in Mozambique: June 2014 – January 2018. PLoS Negl. Trop. Dis. 14, e0008195 (2020).
Nhampossa, T. et al. Diarrheal disease in rural Mozambique: burden, risk factors and etiology of diarrheal disease among children aged 0–59 months seeking care at health facilities. PLoS ONE 10, e0119824 (2015).
Global Health Observatory Data Repository (World Health Organization, 2024). Accessed on August 19, 2025. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/status-of-yawsendemicity.
World Health Organization. Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures (World Health Organization, Geneva, 2016).
Greenhouse, B., Smith, D. L., Rodriguez-Barraquer, I., Mueller, I. & Drakeley, C. J. Taking sharper pictures of malaria with CAMERAs: combined antibodies to measure exposure recency assays. Am. J. Trop. Med. Hyg. 99, 1120–1127 (2018).
Njenga, S. M. et al. Integrated cross-sectional multiplex serosurveillance of IgG antibody responses to parasitic diseases and vaccines in coastal Kenya. Am. J. Trop. Med. Hyg. 102, 164–176 (2020).
Instituto Nacional de Estatística, The DHS Program. Moçambique IDS 2022-2023 – Relatório Definitive (Rockville, Maryland, USA: ICF, 2024).
World Health Organization. Measles Reported Cases and Incidence https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles—number-ofreported-cases (2024).
Fornace, K. M. et al. Characterising spatial patterns of neglected tropical disease transmission using integrated sero-surveillance in Northern Ghana. PLoS Negl. Trop. Dis. 16, e0010227 (2022).
Instituto Nacional de Saude. IV Census 2017 (Instituto Nacional de Estadistica, Maputo, Mozambique, 2019).
Gudo, E. S. Mozambique sample vital statistics system: filling the gaps for mortality data. Am. J. Trop. Med. Hyg. 108, 3–4 (2023).
Rogier, E. et al. Evaluation of immunoglobulin G responses to Plasmodium falciparum and Plasmodium vivax in Malian school children using multiplex bead assay. Am. J. Trop. Med. Hyg. 96, 312–318 (2017).
Rogier, E. et al. High-throughput malaria serosurveillance using a one-step multiplex bead assay. Malar. J. 18, 402 (2019).
Wu, L. et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 4, 26 (2019).
Tohme, R. A. et al. Tetanus and diphtheria seroprotection among children younger than 15 years in Nigeria, 2018: who are the unprotected children? Vaccines (Basel) 11, 663 (2023).
Wu, L. et al. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration. BMC Med. 18, 331 (2020).
Wu, L. et al. Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: results from a secondary analysis of a cluster randomised trial. EClinicalMedicine 44, 101272 (2022).
Briggs, J. et al. Seroprevalence of antibodies to SARS-CoV-2 in rural households in Eastern Uganda, 2020-2022. JAMA Netw. Open 6, e2255978 (2023).
Cooley, G. M. et al. Evaluation of multiplex-based antibody testing for use in large-scale surveillance for yaws: a comparative study. J. Clin. Microbiol 54, 1321–1325 (2016).
Scobie, H. M., Khetsuriani, N., Efstratiou, A. & Priest, J. W. Validation of a diphtheria toxoid multiplex bead assay for serosurveys. Diagn. Microbiol. Infect. Dis. 100, 115371 (2021).
Coughlin, M. M. et al. Development of a measles and rubella multiplex bead serological assay for assessing population immunity. J. Clin. Microbiol. 59, e02716–e02720 (2021).
Scobie, H. M. et al. Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012. Clin. Vaccin. Immunol. 23, 546–554 (2016).
Chan, Y. et al. Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases. PLoS Negl. Trop. Dis. 15, e0009457 (2021).
Hens, N. S. Z., Aerts, M., Faes, C., Van Damme, P. & Beutels, P. Modeling Infectious Disease Parameters Based on Serological and Social Contact Data. 1st ed. (New York, NY: Springer, 2012).
Arnold, B. F. et al. Enteropathogen antibody dynamics and force of infection among children in low-resource setting. Elife 8, e45594 (2019).
Rogan, W. J. & Gladen, B. Estimating prevalence from the results of a screening test. Am. J. Epidemiol. 107, 71–76 (1978).
Hens, N. et al. Seventy-five years of estimating the force of infection from current status data. Epidemiol. Infect. 138, 802–812 (2010).
Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6, e1873 (2012).
Benjamini, Y. H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., Ser. B (Methodol.) 57, 289–300 (1995).
Lin, R., Louis, T. A., Paddock, S. M. & Ridgeway, G. Loss function based ranking in two-stage, hierarchical models. Bayesian Anal. 1, 915–946 (2006).
Chandrashekar, R. et al. Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol. Biochem. Parasitol. 64, 261–271 (1994).
Hamlin, K. L. et al. Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti. PLoS Negl. Trop. Dis. 6, e1941 (2012).
Dissanayake, S., Xu, M., Nkenfou, C. & Piessens, W. F. Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog. Mol. Biochem. Parasitol. 62, 143–146 (1993).
Moss, D. M. et al. Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. Am. J. Trop. Med. Hyg. 85, 229–237 (2011).
Wang, J. et al. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 185, 1670–1680 (2010).
Priest, J. W., Kwon, J. P., Arrowood, M. J. & Lammie, P. J. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol. Biochem. Parasitol. 106, 261–271 (2000).
Moss, D. M., Montgomery, J. M., Newland, S. V., Priest, J. W. & Lammie, P. J. Detection of cryptosporidium antibodies in sera and oral fluids using multiplex bead assay. J. Parasitol. 90, 397–404 (2004).
Priest, J. W. & Moss, D. M. Measuring cryptosporidium serologic responses by multiplex bead assay. Methods Mol. Biol. 2052, 61–85 (2020).
Priest, J. W. et al. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J. Clin. Microbiol. 37, 1385–1392 (1999).
Stickings, P. et al. Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human. Biologicals 41, 384–392 (2013).
Smith, D. B. & Johnson, K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31–40 (1988).
Priest, J. W. et al. Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin. Vaccin. Immunol. 17, 1695–1707 (2010).
Smits, G. P., van Gageldonk, P. G., Schouls, L. M., van der Klis, F. R. & Berbers, G. A. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin. Vaccin. Immunol. 19, 396–400 (2012).
Feeser, K. R. et al. Characterizing reactivity to onchocerca volvulus antigens in multiplex bead assays. Am. J. Trop. Med. Hyg. 97, 666–672 (2017).
Kastenmuller, K. et al. Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I.C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice. Infect. Immun. 81, 789–800 (2013).
Spielmann, T., Fergusen, D. J. & Beck, H. P. Etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface. Mol. Biol. Cell 14, 1529–1544 (2003).
Druetz, T. et al. Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malaria. BMC Infect. Dis. 22, 643 (2022).
Wu, L. et al. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia. BMC Med. 18, 304 (2020).
Helb, D. A. et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc. Natl. Acad. Sci. USA 112, E4438–E4447 (2015).
Theisen, M., Vuust, J., Gottschau, A., Jepsen, S. & Hogh, B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin. Diagn. Lab. Immunol. 2, 30–34 (1995).
Collins, C. R. et al. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J. Biol. Chem. 282, 7431–7441 (2007).
Rogier, E. et al. Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar. J. 14, 436 (2015).
Polley, S. D. et al. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect. Immun. 71, 1833–1842 (2003).
Burghaus, P. A. & Holder, A. A. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Parasitol. 64, 165–169 (1994).
Blackman, M. J., Ling, I. T., Nicholls, S. C. & Holder, A. A. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49, 29–33 (1991).
Egan, A., Waterfall, M., Pinder, M., Holder, A. & Riley, E. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun. 65, 3024–3031 (1997).
Assefa, A. et al. Multiplex serology demonstrate cumulative prevalence and spatial distribution of malaria in Ethiopia. Malar. J. 18, 246 (2019).
Reiling, L. et al. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. PLoS ONE 7, e45253 (2012).
Beeson, J. G. et al. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol. Rev. 40, 343–372 (2016).
Priest, J. W. et al. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1(19) subunit proteins in multiplexed serologic assays. Malar. J. 17, 417 (2018).
Oviedo, A. et al. Spatial cluster analysis of Plasmodium vivax and P. malariae exposure using serological data among Haitian school children sampled between 2014 and 2016. PLoS Negl. Trop. Dis. 16, e0010049 (2022).
Byrne, I. et al. Characterizing the spatial distribution of multiple malaria diagnostic endpoints in a low-transmission setting in Lao PDR. Front. Med. (Lausanne) 9, 929366 (2022).
King, C. L. et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. USA 105, 8363–8368 (2008).
Grimberg, B. T. et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 4, e337 (2007).
Hietanen, J. et al. Gene models, expression repertoire, and immune response of plasmodium vivax reticulocyte binding proteins. Infect. Immun. 84, 677–685 (2015).
Franca, C. T. et al. Plasmodium vivax reticulocyte binding proteins are key targets of naturally acquired immunity in young Papua New Guinean children. PLoS Negl. Trop. Dis. 10, e0005014 (2016).
Noval, M. G. et al. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities. Sci. Rep. 11, 5538 (2021).
Lawal, B. J. et al. Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: a longitudinal study. Int. J. Infect. Dis. 131, 183–192 (2023).
Carter, C. E. & Colley, D. G. An electrophoretic analysis of Schistosoma mansoni soluble egg antigen preparation. J. Parasitol. 64, 285–290 (1978).
Won, K. Y. et al. Multiplex serologic assessment of schistosomiasis in Western Kenya: antibody responses in preschool aged children as a measure of reduced transmission. Am. J. Trop. Med. Hyg. 96, 1460–1467 (2017).
Ali, P. O. et al. Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni. Mol. Biochem. Parasitol. 45, 215–222 (1991).
Tsang, V. C., Hancock, K., Kelly, M. A., Wilson, B. C. & Maddison, S. E. Schistosoma mansoni adult microsomal antigens, a serologic reagent. II. Specificity of antibody responses to the S. mansoni microsomal antigen (MAMA). J. Immunol. 130, 1366–1370 (1983).
Ravi, V., Ramachandran, S., Thompson, R. W., Andersen, J. F. & Neva, F. A. Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Mol. Biochem. Parasitol. 125, 73–81 (2002).
Rascoe, L. N. et al. Development of Ss-NIE-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis. PLoS Negl. Trop. Dis. 9, e0003694 (2015).
Levine, M. Z. et al. Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J. Parasitol. 90, 631–638 (2004).
Hancock, K. et al. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol. 147, 109–117 (2006).
Hernandez-Gonzalez, A., Noh, J., Perteguer, M. J., Garate, T. & Handali, S. Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis. Parasit. Vectors 10, 237 (2017).
Sesardic, D., Wong, M. Y., Gaines Das, R. E. & Corbel, M. J. The first international standard for antitetanus immunoglobulin, human; pharmaceutical evaluation and international collaborative study. Biologicals 21, 67–75 (1993).
Ijsselmuiden, O. E. et al. Sensitivity and specificity of an enzyme-linked immunosorbent assay using the recombinant DNA-derived Treponema pallidum protein TmpA for serodiagnosis of syphilis and the potential use of TmpA for assessing the effect of antibiotic therapy. J. Clin. Microbiol. 27, 152–157 (1989).
Kubofcik, J., Fink, D. L. & Nutman, T. B. Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl. Trop. Dis. 6, e1930 (2012).
Steel, C. et al. Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. Clin. Vaccin. Immunol. 20, 1155–1161 (2013).
Priest, J. W. et al. Integration of multiplex bead assays for parasitic diseases into a national, population-based serosurvey of women 15-39 years of age in Cambodia. PLoS Negl. Trop. Dis. 10, e0004699 (2016).
